All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY3132 | Anti-LYPD3 (XP7-37) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | XP7-37 | LYPD3 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3133 | Anti-LYPD3 (XP7-38) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | XP7-38 | LYPD3 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6385 | Anti-LYPD3 (XP7-37) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | XP7-37 | LYPD3 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6386 | Anti-LYPD3 (XP7-38) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | XP7-38 | LYPD3 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4272 | Anti-LYPD3 (B01-10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | B01-10 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4273 | Anti-LYPD3 (S20H1L1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | S20H1L1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4274 | Anti-LYPD3 (B01-7) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | B01-7 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4483 | Anti-LYPD3 (B01-10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | B01-10 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4484 | Anti-LYPD3 (S20H1L1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | S20H1L1 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-ZP4485 | Anti-LYPD3 (B01-7) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | B01-7 | Human | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION